• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.

作者信息

Roman Eve, Kane Eleanor, Howell Debra, Lamb Maxine, Bagguley Timothy, Crouch Simon, Painter Daniel, Patmore Russell, Smith Alexandra

机构信息

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD, UK.

Queens Centre for Oncology, Castle Hill Hospital, UK.

出版信息

Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275.

DOI:10.1093/ije/dyab275
PMID:35134983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9189975/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/ea23ef2a9505/dyab275f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/c3a55aa86bfd/dyab275f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/235388e13375/dyab275f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/f2ed0e64287b/dyab275f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/ea23ef2a9505/dyab275f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/c3a55aa86bfd/dyab275f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/235388e13375/dyab275f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/f2ed0e64287b/dyab275f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d72/9189975/ea23ef2a9505/dyab275f4.jpg

相似文献

1
Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.队列简介更新：英国血液恶性肿瘤研究网络（HMRN）基于人群的队列。
Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275.
2
Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).利用血液系统恶性肿瘤研究网络（HMRN）的数据估算血液系统恶性肿瘤及其前驱疾病的患病率。
Cancer Causes Control. 2016 Aug;27(8):1019-26. doi: 10.1007/s10552-016-0780-z. Epub 2016 Jun 28.
3
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.各亚型血液恶性肿瘤的发病情况：来自血液恶性肿瘤研究网络的报告。
Br J Cancer. 2011 Nov 22;105(11):1684-92. doi: 10.1038/bjc.2011.450. Epub 2011 Nov 1.
4
Determinants of hospital death in haematological cancers: findings from a qualitative study.血液系统癌症患者医院死亡的决定因素：一项定性研究的结果
BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.
5
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.血液系统恶性肿瘤中戊型肝炎病毒感染风险的特征分析：一项英国前瞻性患病率研究。
Br J Haematol. 2019 Jul;186(1):191-195. doi: 10.1111/bjh.15796. Epub 2019 Feb 15.
6
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.血液恶性肿瘤研究网络（HMRN）：一种基于人群的流行病学和卫生服务研究的新信息策略。
Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1.
7
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.队列简介：血液恶性肿瘤研究网络（HMRN）：一个基于英国人群的患者队列。
Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.
8
Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).血液系统癌症：改善治疗效果。关于专科综合血液系统恶性肿瘤诊断服务（SIHMDS）的最新英国国家卫生与临床优化研究所（NICE）服务指南总结。
J Clin Pathol. 2017 Jun;70(6):461-468. doi: 10.1136/jclinpath-2016-204029. Epub 2017 Apr 7.
9
Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.姑息治疗专家对转介血液科患者至其服务的看法：一项定性研究的结果。
BMC Palliat Care. 2018 Feb 21;17(1):33. doi: 10.1186/s12904-018-0289-1.
10
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.2004 - 2014年淋巴瘤的发病率、生存率和患病率：来自英国血液恶性肿瘤研究网络的亚型分析
Br J Cancer. 2015 Apr 28;112(9):1575-84. doi: 10.1038/bjc.2015.94. Epub 2015 Mar 24.

引用本文的文献

1
Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective.使用真实世界证据进行匹配调整间接比较中的不确定性：证据评估小组观点
Pharmacoeconomics. 2025 May;43(5):469-472. doi: 10.1007/s40273-025-01480-5. Epub 2025 Mar 21.
2
Information preferences of patients with chronic blood cancer: A qualitative investigation.慢性血液病患者的信息偏好：一项定性研究。
PLoS One. 2024 Aug 20;19(8):e0293772. doi: 10.1371/journal.pone.0293772. eCollection 2024.
3
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

本文引用的文献

1
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.《全国癌症状况年度报告》第 1 部分：国家癌症统计。
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131.
2
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.意义未明的单克隆丙种球蛋白血症（MGUS）和单克隆 B 细胞淋巴增生症（MBL）的健康影响：来自英国基于人群的队列研究结果。
BMJ Open. 2021 Feb 22;11(2):e041296. doi: 10.1136/bmjopen-2020-041296.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
淋巴瘤预后的流行病学队列研究：设计、基线特征及早期预后
Am J Hematol. 2024 Mar;99(3):408-421. doi: 10.1002/ajh.27202. Epub 2024 Jan 13.
4
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.REALYSA 中弥漫性大 B 细胞淋巴瘤真实世界数据的质量和利用面临的挑战，这是一个 LYSA 队列。
Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798.
5
Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers.慢性血液系统癌症患者的心理社会支持体验和偏好：一项探索患者观点的定性研究。
BMJ Open. 2023 Aug 18;13(8):e070467. doi: 10.1136/bmjopen-2022-070467.
6
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.滤泡性淋巴瘤的分子亚群：来自英国血液恶性肿瘤研究网络的报告。
Blood Adv. 2022 Nov 8;6(21):5716-5731. doi: 10.1182/bloodadvances.2021005284.
《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network.血液恶性肿瘤患者的首选和实际死亡地点：来自英国血液恶性肿瘤研究网络的报告。
BMJ Support Palliat Care. 2021 Mar;11(1):7-16. doi: 10.1136/bmjspcare-2019-002097. Epub 2020 May 11.
5
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.弥漫性大 B 细胞淋巴瘤的靶向测序、分子亚型与结局：血液系统恶性肿瘤研究网络报告
Blood. 2020 May 14;135(20):1759-1771. doi: 10.1182/blood.2019003535.
6
Experiences of living with chronic myeloid leukaemia and adhering to tyrosine kinase inhibitors: A thematic synthesis of qualitative studies.与慢性髓性白血病共存并坚持使用酪氨酸激酶抑制剂的体验：定性研究的主题综合分析。
Eur J Oncol Nurs. 2020 Apr;45:101730. doi: 10.1016/j.ejon.2020.101730. Epub 2020 Feb 11.
7
'Unpacking' pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives.解析淋巴瘤和骨髓瘤诊断的途径：患者和家属的英国定性研究结果表明，其经历与治疗途径模型是否一致。
BMJ Open. 2020 Feb 12;10(2):e034244. doi: 10.1136/bmjopen-2019-034244.
8
Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network.霍奇金淋巴瘤的检测与生存率：血液恶性肿瘤研究网络的研究结果
BJGP Open. 2019 Dec 10;3(4). doi: 10.3399/bjgpopen19X101668.
9
Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.关节置换术后成熟 B 细胞肿瘤和前体疾病的风险：来自血液系统恶性肿瘤研究网络的报告。
Int J Cancer. 2020 Aug 1;147(3):702-708. doi: 10.1002/ijc.32765. Epub 2019 Nov 23.
10
Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study.血液学护士对其患者护理场所和死亡地点的看法：一项英国定性访谈研究。
Eur J Oncol Nurs. 2019 Apr;39:70-80. doi: 10.1016/j.ejon.2019.02.003. Epub 2019 Feb 7.